Stockreport

Neoleukin Therapeutics Announces 1-for-5 Reverse Stock Split

Neoleukin Therapeutics, Inc.  (NLTX) 
PDF SEATTLE, Sept. 22, 2023 (GLOBE NEWSWIRE) -- Neoleukin Therapeutics, Inc., “Neoleukin” or the “Company” (NASDAQ:NLTX), a biopharmaceutical company that has designed de [Read more]